Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 22544194.
- Also identified by DOI 10.1093/cid/cir1014 and PMC identifier 3338304.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Monitoring human immunodeficiency virus drug resistance (HIVDR) early warning indicators (EWIs) can help national antiretroviral treatment (ART) programs to identify clinic factors associated with HIVDR emergence and provide evidence to support national program and clinic-level adjustments, if necessary. World Health Organization-recommended HIVDR EWIs were monitored in Zimbabwe using routinely available data at selected ART clinics between 2007 and 2009. As Zimbabwe's national ART coverage increases, improved ART information systems are required to strengthen routine national ART monitoring and evaluation and facilitate scale-up of HIVDR EWI monitoring. Attention should be paid to minimizing loss to follow-up, supporting adherence, and ensuring clinic-level drug supply continuity.
Medical subject headings
- Anti-Retroviral Agents
- HIV Infections